Table of Content

Executive Summary

Chapter 1 – Introduction

Chapter 2 – Trends in Biotech dealmaking

2.1. Introduction
2.2. Biotech partnering over the years
2.3. Most active Biotech dealmakers
2.4. Biotech partnering by deal type
2.5. Biotech partnering by therapy area
2.6. Biotech partnering by technology type
2.7. Deal terms for Biotech partnering
2.7.1 Biotech partnering headline values
2.7.2 Biotech deal upfront payments
2.7.3 Biotech deal milestone payments
2.7.4 Biotech royalty rates

Chapter 3 – Leading Biotech deals

3.1. Introduction
3.2. Top Biotech deals by value

Chapter 4 – Most active Biotech dealmakers

4.1. Introduction
4.2. Most active Biotech dealmakers
4.3. Most active Biotech partnering company profiles

Chapter 5 – Biotech contracts dealmaking directory

5.1. Introduction
5.2. Biotech contracts dealmaking directory

Chapter 6 – Biotech dealmaking by technology type

Chapter 7 – Partnering resource center

7.1. Online partnering
7.2. Partnering events
7.3. Further reading on dealmaking

Appendices

Appendix 1 – Biotech deals by company A-Z
Appendix 2 – Biotech deals by stage of development
Appendix 3 – Biotech deals by deal type
Appendix 4 – Biotech deals by therapy area
Appendix 5 – Deal type definitions

 



Table of figures

Figure 1: Biotech partnering since 2014
Figure 2: Active Biotech dealmaking activity since 2014
Figure 3: Biotech partnering by deal type since 2014
Figure 4: Biotech partnering by disease type since 2014
Figure 5: Biotech partnering by technology type since 2014
Figure 6: Biotech deals with a headline value
Figure 7: Biotech deals with an upfront value
Figure 8: Biotech deals with a milestone value
Figure 9: Biotech deals with a royalty rate value
Figure 10: Top Biotech deals by value since 2014
Figure 11: Most active Biotech dealmakers since 2014
Figure 12: Online partnering resources
Figure 13: Forthcoming partnering events